Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by <em>Escherichia coli</em> or <em>Klebsiella pneumoniae</em>: The Role of Prior Exposure to Fluoroquinolones
Javier Martínez-Casanova,
Silvia Gómez-Zorrilla,
Nuria Prim,
Agustina Dal Molin,
Daniel Echeverría-Esnal,
María Pilar Gracia-Arnillas,
Elena Sendra,
Robert Güerri-Fernández,
Xavier Durán-Jordà,
Eduardo Padilla,
Juan Pablo Horcajada,
Santiago Grau,
on behalf of the PROA-PSMAR Group
Affiliations
Javier Martínez-Casanova
Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain
Silvia Gómez-Zorrilla
Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Nuria Prim
Microbiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Agustina Dal Molin
Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Daniel Echeverría-Esnal
Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain
María Pilar Gracia-Arnillas
Critical Care Department, GREPAC, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain
Elena Sendra
Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Robert Güerri-Fernández
Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Xavier Durán-Jordà
Scientific, Statistics and Technical Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain
Eduardo Padilla
Microbiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Juan Pablo Horcajada
Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS—Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain
Santiago Grau
Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain
Background: High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in patients with community-onset UTI in emergency departments (EDs). Methods: A retrospective study was performed of all ED patients with positive urine cultures for Escherichia coli or Klebsiella pneumoniae in a Spanish tertiary-care hospital. Results: 330 urine cultures in all were included: 261 (79.1%) for E. coli and 69 (20.90%) for K. pneumonia. Rates of AMC resistance were 14.94% and 34.78%, respectively. UTI was clinically confirmed in 212 (64.24%) cases. Previous antimicrobial exposure was independently associated with AMC resistance development in E. coli and K. pneumoniae urinary isolates (OR = 2.94, 95% CI = 1.55–5.58). Analyses of infected patients revealed that previous exposure to fluoroquinolones (OR = 3.33, 95% CI = 1.10–10.12, p = 0.034) and to AMC (OR = 5.68, 95% CI = 1.97–16.44, p = 0.001) was significantly associated with isolation of AMC-resistant strains. Conclusions: Prior antibiotic exposure, particularly to AMC or fluoroquinolones, was the only independent risk factor associated with development of AMC resistance in E. coli and K. pneumoniae urinary isolates from patients attending the ED.